Phospholipase D family member 5 pseudogene (PLD5P)

The phospholipase D family member 5 pseudogene (PLD5P) is classified as a processed pseudogene according to Genecards and genomic biotype sources[8][2]. Pseudogenes are DNA sequences that resemble protein-coding genes but have lost their protein-coding ability or are otherwise no longer functional, typically due to mutations that disrupt their normal transcription or translation. As such, PLD5P does not code for an active enzyme and is not known to have direct biological function or involvement in disease mechanisms. It is not considered a therapeutic target, nor are there known drugs, safety concerns, or biomarker utility associated with it. The presence of "pseudogene" in the name and annotation indicates it is a genomic relic and not an active member of the phospholipase D family[2][8]. Key Points: - PLD5P is a processed pseudogene—an inactive copy of the PLD5 gene that arose from reverse transcription and reintegration of mRNA into the genome[2]. - It is not a functional enzyme, receptor, or other typical drug target; thus, it lacks drug interactions, mechanisms of action, and disease associations. - There is nothing to suggest biological activity, clinical relevance, or targeting rationale for this entry. - Presence in databases simply denotes its sequence homology to phospholipase D family member 5 but lack of function renders it scientifically uninteresting outside of evolutionary genomics.

Other names

Phospholipase D family member 5 pseudogenePLD5PPLD5 pseudogene